Cargando…
Targeting eIF4F translation initiation complex with SBI-756 sensitises B lymphoma cells to venetoclax
BACKGROUND: The BCL2 inhibitor venetoclax has shown efficacy in several hematologic malignancies, with the greatest response rates in indolent blood cancers such as chronic lymphocytic leukaemia. There is a lower response rate to venetoclax monotherapy in diffuse large B-cell lymphoma (DLBCL). METHO...
Autores principales: | Herzog, Lee-or, Walters, Beth, Buono, Roberta, Lee, J. Scott, Mallya, Sharmila, Fung, Amos, Chiu, Honyin, Nguyen, Nancy, Li, Boyang, Pinkerton, Anthony B., Jackson, Michael R., Schneider, Robert J., Ronai, Ze’ev A., Fruman, David A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960756/ https://www.ncbi.nlm.nih.gov/pubmed/33318657 http://dx.doi.org/10.1038/s41416-020-01205-9 |
Ejemplares similares
-
Reduced eIF4E function impairs B-cell leukemia without altering normal B-lymphocyte function
por: Chiu, Honyin, et al.
Publicado: (2021) -
Targeting eIF4F translation complex sensitizes B-ALL cells to tyrosine kinase inhibition
por: Vo, Thanh-Trang, et al.
Publicado: (2021) -
Efficacy of a Novel Bi-Steric mTORC1 Inhibitor in Models of B-Cell Acute Lymphoblastic Leukemia
por: Lee, Bianca J., et al.
Publicado: (2021) -
mTOR inhibition enhances efficacy of dasatinib in ABL-rearranged Ph-like B-ALL
por: Gotesman, Moran, et al.
Publicado: (2018) -
Start-up costs of implementing Screening and Brief Intervention (SBI) for Adolescents (part of Economics of SBI symposium)
por: Barbosa, Carolina, et al.
Publicado: (2015)